Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Studies on suppressor cell function in thyroid diseases.

N Aoki, K M Pinnamaneni, L J DeGroot

    The Journal of Clinical Endocrinology and Metabolism
    |May 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    "Non-thyroidal illness syndrome" is functional central hypothyroidism, and if severe, hormone replacement is appropriate in light of present knowledge.

    Journal of endocrinological investigation·2004
    Same author

    Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease.

    Journal of endocrinological investigation·2002
    Same author

    Effective gene therapy for medullary thyroid carcinoma using recombinant adenovirus inducing tumor-specific expression of interleukin-12.

    Gene therapy·2002
    Same author

    Treatment of multinodular goiter by surgery.

    Journal of endocrinological investigation·2002
    Same author

    An adenoviral vector expressing functional heterogeneous proteins herpes simplex viral thymidine kinase and human interleukin-2 has enhanced in vivo antitumor activity against medullary thyroid carcinoma.

    Endocrine-related cancer·2001
    Same author

    Clinical review 131: Gene therapy for thyroid cancer: where do we stand?

    The Journal of clinical endocrinology and metabolism·2001

    Suppressor cell function is significantly reduced in Graves' disease patients, suggesting a potential inherited immune abnormality. This immune dysfunction persists even after treatment for Graves' disease.

    Area of Science:

    • Immunology
    • Endocrinology
    • Thyroid Disorders

    Background:

    • Peripheral mononuclear cells (PMNs) play a crucial role in immune regulation.
    • Alterations in suppressor cell function are implicated in various autoimmune and endocrine diseases.
    • Graves' disease, Hashimoto's thyroiditis, and thyroid cancer involve complex immune system interactions.

    Purpose of the Study:

    • To investigate suppressor cell function in patients with Graves' disease, Hashimoto's thyroiditis, and thyroid cancer.
    • To compare immune cell activity in these patient groups with healthy controls.
    • To determine if suppressor cell dysfunction in Graves' disease is a persistent or treatable characteristic.

    Main Methods:

    • Assessed suppressor cell function using two distinct methods: enhanced blastogenesis and concanavalin A-inducible suppressor activity.

    Related Experiment Videos

  • Evaluated peripheral mononuclear cells from patients with Graves' disease, Hashimoto's thyroiditis, thyroid cancer, and healthy individuals.
  • Compared suppressor cell activity between patient cohorts and control groups.

    • Main Results:

    • Significantly decreased suppressor cell function was observed in patients with Graves' disease compared to healthy controls.
    • No significant changes in suppressor cell function were detected in patients with Hashimoto's thyroiditis or thyroid cancer.
    • Impaired suppressor cell function persisted in treated Graves' disease patients, although function was improved compared to untreated individuals.

    Conclusions:

    • Reduced suppressor cell function may be a constitutional, inherited trait specific to Graves' disease.
    • The immune dysfunction in Graves' disease appears to be a long-standing characteristic, not solely due to active hyperthyroidism.
    • Further research into the genetic basis of immune dysregulation in Graves' disease is warranted.